Home › Proteinuria
Proteinuria clinical trials recruiting in the U.S.
17 studies for Proteinuria are recruiting participants at sites across the United States.
Cities with the most studies
- Miami, FL4 studies
- Aurora, CO4 studies
- Houston, TX4 studies
- Arvada, CO3 studies
- Cedar Rapids, IA3 studies
- Washington, DC3 studies
- Orlando, FL3 studies
- Salt Lake City, UT3 studies
By state
- California6 studies
- Colorado8 studies
- Florida8 studies
- Georgia5 studies
- Iowa3 studies
- Maryland4 studies
- Massachusetts3 studies
- Pennsylvania5 studies
- Texas5 studies
- Utah3 studies
Recently updated studies
Urinary Vitamin C Loss in Diabetic Subjects
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Nov 12, 2026 · NCT00071526Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria
Recruiting
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07431931A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07268638Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
RecruitingPhase 3
Ages 12 to 60 · All sexes · Updated Nov 5, 2026 · NCT04817618A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07902817A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
RecruitingPhase 2
Ages 18 to 60 · All sexes · Updated Oct 30, 2026 · NCT07541287An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases
RecruitingPhase 2
Ages 18 to 115 · All sexes · Updated Oct 30, 2026 · NCT06664814Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
RecruitingPhase 2
Ages 18 to 90 · All sexes · Updated Oct 26, 2026 · NCT00977977A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT07146906Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Sep 9, 2026 · NCT06994845Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT07224776Study of Ravulizumab in Pediatric Participants With Primary IgAN
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Jul 30, 2026 · NCT07024563Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
RecruitingPhase 3
Ages 12 to 60 · All sexes · Updated Jul 13, 2026 · NCT05755386Study of BHV-1400 in IgA Nephropathy
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 23, 2026 · NCT07054684Empagliflozin Treatment in Kidney Transplant Recipients
RecruitingPhase 4
Ages 19 and older · All sexes · Updated Apr 21, 2026 · NCT06013865Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
RecruitingObservational studyHealthy volunteers welcome
Ages 7 to 18 · All sexes · Updated Dec 11, 2025 · NCT04752293Proteinuria in Pre and Post Transplant
RecruitingObservational study
Up to age 25 · All sexes · Updated Nov 21, 2025 · NCT01094327From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.